A major contributor to poor sensitivity to anti-cancer kinase inhibitor therapy is drug-induced cellular adaptation,…
karnottMarch 27, 2025
In a provocative new essay published in PLOS Biology, ISB Professor Sui Huang and colleagues…
karnottMarch 27, 2025
Dr. Andrew Stergachis: ‘We were able to precisely resolve the genetic and molecular basis of…
karnottMarch 26, 2025
The Institute of Translational Health Sciences is pleased to announce the Pilot Award recipients for…
karnottMarch 26, 2025
After raising $28.3 million, Bothell-based VerAvanti is expanding its footprint in the Seattle region. Founded…
karnottMarch 25, 2025
In a recent letter in the Journal of Allergy and Clinical Immunology, researchers from Benaroya…
karnottMarch 25, 2025
Dravet syndrome (DS) is a severe and difficult-to-treat epileptic syndrome usually caused by a loss-of-function…
karnottMarch 25, 2025
Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110M in a Series…
karnottMarch 24, 2025
The GeekWire Awards finalists for Health Innovation of the Year are dominated by ventures that…
karnottMarch 24, 2025
